 | • レポートコード：QFJ1-3368 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：3日） • 産業分類：産業装置 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、細胞治療処理の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（製品、サービス、ソフトウェア）、用途別市場規模（心血管疾患、骨修復、神経障害、骨格筋修復免疫疾患）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・細胞治療処理の市場動向 ・企業の競争状況、市場シェア ・細胞治療処理の種類別市場規模と予測2016-2027（製品、サービス、ソフトウェア） ・細胞治療処理の用途別市場規模と予測2016-2027（心血管疾患、骨修復、神経障害、骨格筋修復免疫疾患） ・細胞治療処理の北米市場規模2016-2027（アメリカ、カナダ） ・細胞治療処理の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・細胞治療処理のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・細胞治療処理の中南米市場規模2016-2027（メキシコ、ブラジル） ・細胞治療処理の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Anthrogenesis Corp.、BioNTech、Cell Ideas、Epic Sciences、Roche、FuGENE、IBC Pharmaceuticals Inc.、Bluebird Bio Inc.、Immodulon-Therapeutics、Immunomedics Inc.、Juno Therapeutics Inc.、Medlmmune Inc.、NeoStem Oncology、Neurotech USA、Novartis、Persimmune Inc.、Pluristem Therapeutics、BioMed Valley Discoveries Inc.、Regeneron Pharmaceuticals Inc.、UCL Business PLC.） ・結論 |
Market Analysis and Insights: Global Cell therapy Processing Market
The global Cell therapy Processing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell therapy Processing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell therapy Processing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell therapy Processing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell therapy Processing market.
Global Cell therapy Processing Scope and Market Size
Cell therapy Processing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell therapy Processing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Products
Services
Software
Segment by Application
Cardiovascular Disease
Bone Repair
Neurological Disorders
Skeletal Muscle RepairImmune Diseases
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Anthrogenesis Corp.
BioNTech
Cell Ideas
Epic Sciences
Roche
FuGENE
IBC Pharmaceuticals Inc.
Bluebird Bio Inc.
Immodulon-Therapeutics
Immunomedics Inc.
Juno Therapeutics Inc.
Medlmmune Inc.
NeoStem Oncology
Neurotech USA
Novartis
Persimmune Inc.
Pluristem Therapeutics
BioMed Valley Discoveries Inc.
Regeneron Pharmaceuticals Inc.
UCL Business PLC.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell therapy Processing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Products
1.2.3 Services
1.2.4 Software
1.3 Market by Application
1.3.1 Global Cell therapy Processing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cardiovascular Disease
1.3.3 Bone Repair
1.3.4 Neurological Disorders
1.3.5 Skeletal Muscle RepairImmune Diseases
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell therapy Processing Market Perspective (2016-2027)
2.2 Cell therapy Processing Growth Trends by Regions
2.2.1 Cell therapy Processing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cell therapy Processing Historic Market Share by Regions (2016-2021)
2.2.3 Cell therapy Processing Forecasted Market Size by Regions (2022-2027)
2.3 Cell therapy Processing Industry Dynamic
2.3.1 Cell therapy Processing Market Trends
2.3.2 Cell therapy Processing Market Drivers
2.3.3 Cell therapy Processing Market Challenges
2.3.4 Cell therapy Processing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell therapy Processing Players by Revenue
3.1.1 Global Top Cell therapy Processing Players by Revenue (2016-2021)
3.1.2 Global Cell therapy Processing Revenue Market Share by Players (2016-2021)
3.2 Global Cell therapy Processing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cell therapy Processing Revenue
3.4 Global Cell therapy Processing Market Concentration Ratio
3.4.1 Global Cell therapy Processing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell therapy Processing Revenue in 2020
3.5 Cell therapy Processing Key Players Head office and Area Served
3.6 Key Players Cell therapy Processing Product Solution and Service
3.7 Date of Enter into Cell therapy Processing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell therapy Processing Breakdown Data by Type
4.1 Global Cell therapy Processing Historic Market Size by Type (2016-2021)
4.2 Global Cell therapy Processing Forecasted Market Size by Type (2022-2027)
5 Cell therapy Processing Breakdown Data by Application
5.1 Global Cell therapy Processing Historic Market Size by Application (2016-2021)
5.2 Global Cell therapy Processing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cell therapy Processing Market Size (2016-2027)
6.2 North America Cell therapy Processing Market Size by Type
6.2.1 North America Cell therapy Processing Market Size by Type (2016-2021)
6.2.2 North America Cell therapy Processing Market Size by Type (2022-2027)
6.2.3 North America Cell therapy Processing Market Size by Type (2016-2027)
6.3 North America Cell therapy Processing Market Size by Application
6.3.1 North America Cell therapy Processing Market Size by Application (2016-2021)
6.3.2 North America Cell therapy Processing Market Size by Application (2022-2027)
6.3.3 North America Cell therapy Processing Market Size by Application (2016-2027)
6.4 North America Cell therapy Processing Market Size by Country
6.4.1 North America Cell therapy Processing Market Size by Country (2016-2021)
6.4.2 North America Cell therapy Processing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cell therapy Processing Market Size (2016-2027)
7.2 Europe Cell therapy Processing Market Size by Type
7.2.1 Europe Cell therapy Processing Market Size by Type (2016-2021)
7.2.2 Europe Cell therapy Processing Market Size by Type (2022-2027)
7.2.3 Europe Cell therapy Processing Market Size by Type (2016-2027)
7.3 Europe Cell therapy Processing Market Size by Application
7.3.1 Europe Cell therapy Processing Market Size by Application (2016-2021)
7.3.2 Europe Cell therapy Processing Market Size by Application (2022-2027)
7.3.3 Europe Cell therapy Processing Market Size by Application (2016-2027)
7.4 Europe Cell therapy Processing Market Size by Country
7.4.1 Europe Cell therapy Processing Market Size by Country (2016-2021)
7.4.2 Europe Cell therapy Processing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cell therapy Processing Market Size (2016-2027)
8.2 Asia-Pacific Cell therapy Processing Market Size by Type
8.2.1 Asia-Pacific Cell therapy Processing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cell therapy Processing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cell therapy Processing Market Size by Type (2016-2027)
8.3 Asia-Pacific Cell therapy Processing Market Size by Application
8.3.1 Asia-Pacific Cell therapy Processing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cell therapy Processing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cell therapy Processing Market Size by Application (2016-2027)
8.4 Asia-Pacific Cell therapy Processing Market Size by Region
8.4.1 Asia-Pacific Cell therapy Processing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cell therapy Processing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cell therapy Processing Market Size (2016-2027)
9.2 Latin America Cell therapy Processing Market Size by Type
9.2.1 Latin America Cell therapy Processing Market Size by Type (2016-2021)
9.2.2 Latin America Cell therapy Processing Market Size by Type (2022-2027)
9.2.3 Latin America Cell therapy Processing Market Size by Type (2016-2027)
9.3 Latin America Cell therapy Processing Market Size by Application
9.3.1 Latin America Cell therapy Processing Market Size by Application (2016-2021)
9.3.2 Latin America Cell therapy Processing Market Size by Application (2022-2027)
9.3.3 Latin America Cell therapy Processing Market Size by Application (2016-2027)
9.4 Latin America Cell therapy Processing Market Size by Country
9.4.1 Latin America Cell therapy Processing Market Size by Country (2016-2021)
9.4.2 Latin America Cell therapy Processing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell therapy Processing Market Size (2016-2027)
10.2 Middle East & Africa Cell therapy Processing Market Size by Type
10.2.1 Middle East & Africa Cell therapy Processing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cell therapy Processing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cell therapy Processing Market Size by Type (2016-2027)
10.3 Middle East & Africa Cell therapy Processing Market Size by Application
10.3.1 Middle East & Africa Cell therapy Processing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cell therapy Processing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cell therapy Processing Market Size by Application (2016-2027)
10.4 Middle East & Africa Cell therapy Processing Market Size by Country
10.4.1 Middle East & Africa Cell therapy Processing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cell therapy Processing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Anthrogenesis Corp.
11.1.1 Anthrogenesis Corp. Company Details
11.1.2 Anthrogenesis Corp. Business Overview
11.1.3 Anthrogenesis Corp. Cell therapy Processing Introduction
11.1.4 Anthrogenesis Corp. Revenue in Cell therapy Processing Business (2016-2021)
11.1.5 Anthrogenesis Corp. Recent Development
11.2 BioNTech
11.2.1 BioNTech Company Details
11.2.2 BioNTech Business Overview
11.2.3 BioNTech Cell therapy Processing Introduction
11.2.4 BioNTech Revenue in Cell therapy Processing Business (2016-2021)
11.2.5 BioNTech Recent Development
11.3 Cell Ideas
11.3.1 Cell Ideas Company Details
11.3.2 Cell Ideas Business Overview
11.3.3 Cell Ideas Cell therapy Processing Introduction
11.3.4 Cell Ideas Revenue in Cell therapy Processing Business (2016-2021)
11.3.5 Cell Ideas Recent Development
11.4 Epic Sciences
11.4.1 Epic Sciences Company Details
11.4.2 Epic Sciences Business Overview
11.4.3 Epic Sciences Cell therapy Processing Introduction
11.4.4 Epic Sciences Revenue in Cell therapy Processing Business (2016-2021)
11.4.5 Epic Sciences Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Cell therapy Processing Introduction
11.5.4 Roche Revenue in Cell therapy Processing Business (2016-2021)
11.5.5 Roche Recent Development
11.6 FuGENE
11.6.1 FuGENE Company Details
11.6.2 FuGENE Business Overview
11.6.3 FuGENE Cell therapy Processing Introduction
11.6.4 FuGENE Revenue in Cell therapy Processing Business (2016-2021)
11.6.5 FuGENE Recent Development
11.7 IBC Pharmaceuticals Inc.
11.7.1 IBC Pharmaceuticals Inc. Company Details
11.7.2 IBC Pharmaceuticals Inc. Business Overview
11.7.3 IBC Pharmaceuticals Inc. Cell therapy Processing Introduction
11.7.4 IBC Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2016-2021)
11.7.5 IBC Pharmaceuticals Inc. Recent Development
11.8 Bluebird Bio Inc.
11.8.1 Bluebird Bio Inc. Company Details
11.8.2 Bluebird Bio Inc. Business Overview
11.8.3 Bluebird Bio Inc. Cell therapy Processing Introduction
11.8.4 Bluebird Bio Inc. Revenue in Cell therapy Processing Business (2016-2021)
11.8.5 Bluebird Bio Inc. Recent Development
11.9 Immodulon-Therapeutics
11.9.1 Immodulon-Therapeutics Company Details
11.9.2 Immodulon-Therapeutics Business Overview
11.9.3 Immodulon-Therapeutics Cell therapy Processing Introduction
11.9.4 Immodulon-Therapeutics Revenue in Cell therapy Processing Business (2016-2021)
11.9.5 Immodulon-Therapeutics Recent Development
11.10 Immunomedics Inc.
11.10.1 Immunomedics Inc. Company Details
11.10.2 Immunomedics Inc. Business Overview
11.10.3 Immunomedics Inc. Cell therapy Processing Introduction
11.10.4 Immunomedics Inc. Revenue in Cell therapy Processing Business (2016-2021)
11.10.5 Immunomedics Inc. Recent Development
11.11 Juno Therapeutics Inc.
11.11.1 Juno Therapeutics Inc. Company Details
11.11.2 Juno Therapeutics Inc. Business Overview
11.11.3 Juno Therapeutics Inc. Cell therapy Processing Introduction
11.11.4 Juno Therapeutics Inc. Revenue in Cell therapy Processing Business (2016-2021)
11.11.5 Juno Therapeutics Inc. Recent Development
11.12 Medlmmune Inc.
11.12.1 Medlmmune Inc. Company Details
11.12.2 Medlmmune Inc. Business Overview
11.12.3 Medlmmune Inc. Cell therapy Processing Introduction
11.12.4 Medlmmune Inc. Revenue in Cell therapy Processing Business (2016-2021)
11.12.5 Medlmmune Inc. Recent Development
11.13 NeoStem Oncology
11.13.1 NeoStem Oncology Company Details
11.13.2 NeoStem Oncology Business Overview
11.13.3 NeoStem Oncology Cell therapy Processing Introduction
11.13.4 NeoStem Oncology Revenue in Cell therapy Processing Business (2016-2021)
11.13.5 NeoStem Oncology Recent Development
11.14 Neurotech USA
11.14.1 Neurotech USA Company Details
11.14.2 Neurotech USA Business Overview
11.14.3 Neurotech USA Cell therapy Processing Introduction
11.14.4 Neurotech USA Revenue in Cell therapy Processing Business (2016-2021)
11.14.5 Neurotech USA Recent Development
11.15 Novartis
11.15.1 Novartis Company Details
11.15.2 Novartis Business Overview
11.15.3 Novartis Cell therapy Processing Introduction
11.15.4 Novartis Revenue in Cell therapy Processing Business (2016-2021)
11.15.5 Novartis Recent Development
11.16 Persimmune Inc.
11.16.1 Persimmune Inc. Company Details
11.16.2 Persimmune Inc. Business Overview
11.16.3 Persimmune Inc. Cell therapy Processing Introduction
11.16.4 Persimmune Inc. Revenue in Cell therapy Processing Business (2016-2021)
11.16.5 Persimmune Inc. Recent Development
11.17 Pluristem Therapeutics
11.17.1 Pluristem Therapeutics Company Details
11.17.2 Pluristem Therapeutics Business Overview
11.17.3 Pluristem Therapeutics Cell therapy Processing Introduction
11.17.4 Pluristem Therapeutics Revenue in Cell therapy Processing Business (2016-2021)
11.17.5 Pluristem Therapeutics Recent Development
11.18 BioMed Valley Discoveries Inc.
11.18.1 BioMed Valley Discoveries Inc. Company Details
11.18.2 BioMed Valley Discoveries Inc. Business Overview
11.18.3 BioMed Valley Discoveries Inc. Cell therapy Processing Introduction
11.18.4 BioMed Valley Discoveries Inc. Revenue in Cell therapy Processing Business (2016-2021)
11.18.5 BioMed Valley Discoveries Inc. Recent Development
11.18 Regeneron Pharmaceuticals Inc.
.1 Regeneron Pharmaceuticals Inc. Company Details
.2 Regeneron Pharmaceuticals Inc. Business Overview
.3 Regeneron Pharmaceuticals Inc. Cell therapy Processing Introduction
.4 Regeneron Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2016-2021)
.5 Regeneron Pharmaceuticals Inc. Recent Development
11.20 UCL Business PLC.
11.20.1 UCL Business PLC. Company Details
11.20.2 UCL Business PLC. Business Overview
11.20.3 UCL Business PLC. Cell therapy Processing Introduction
11.20.4 UCL Business PLC. Revenue in Cell therapy Processing Business (2016-2021)
11.20.5 UCL Business PLC. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cell therapy Processing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Products
Table 3. Key Players of Services
Table 4. Key Players of Software
Table 5. Global Cell therapy Processing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cell therapy Processing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cell therapy Processing Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Cell therapy Processing Market Share by Regions (2016-2021)
Table 9. Global Cell therapy Processing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Cell therapy Processing Market Share by Regions (2022-2027)
Table 11. Cell therapy Processing Market Trends
Table 12. Cell therapy Processing Market Drivers
Table 13. Cell therapy Processing Market Challenges
Table 14. Cell therapy Processing Market Restraints
Table 15. Global Cell therapy Processing Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Cell therapy Processing Market Share by Players (2016-2021)
Table 17. Global Top Cell therapy Processing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell therapy Processing as of 2020)
Table 18. Ranking of Global Top Cell therapy Processing Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Cell therapy Processing Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cell therapy Processing Product Solution and Service
Table 22. Date of Enter into Cell therapy Processing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cell therapy Processing Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Cell therapy Processing Revenue Market Share by Type (2016-2021)
Table 26. Global Cell therapy Processing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Cell therapy Processing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Cell therapy Processing Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Cell therapy Processing Revenue Market Share by Application (2016-2021)
Table 30. Global Cell therapy Processing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Cell therapy Processing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Cell therapy Processing Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Cell therapy Processing Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Cell therapy Processing Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Cell therapy Processing Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Cell therapy Processing Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Cell therapy Processing Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Cell therapy Processing Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Cell therapy Processing Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Cell therapy Processing Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Cell therapy Processing Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Cell therapy Processing Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Cell therapy Processing Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Cell therapy Processing Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Cell therapy Processing Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cell therapy Processing Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cell therapy Processing Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cell therapy Processing Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Cell therapy Processing Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Cell therapy Processing Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Cell therapy Processing Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Cell therapy Processing Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Cell therapy Processing Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Cell therapy Processing Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Cell therapy Processing Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Cell therapy Processing Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Cell therapy Processing Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cell therapy Processing Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cell therapy Processing Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cell therapy Processing Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Cell therapy Processing Market Size by Country (2022-2027) & (US$ Million)
Table 62. Anthrogenesis Corp. Company Details
Table 63. Anthrogenesis Corp. Business Overview
Table 64. Anthrogenesis Corp. Cell therapy Processing Product
Table 65. Anthrogenesis Corp. Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 66. Anthrogenesis Corp. Recent Development
Table 67. BioNTech Company Details
Table 68. BioNTech Business Overview
Table 69. BioNTech Cell therapy Processing Product
Table 70. BioNTech Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 71. BioNTech Recent Development
Table 72. Cell Ideas Company Details
Table 73. Cell Ideas Business Overview
Table 74. Cell Ideas Cell therapy Processing Product
Table 75. Cell Ideas Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 76. Cell Ideas Recent Development
Table 77. Epic Sciences Company Details
Table 78. Epic Sciences Business Overview
Table 79. Epic Sciences Cell therapy Processing Product
Table 80. Epic Sciences Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 81. Epic Sciences Recent Development
Table 82. Roche Company Details
Table 83. Roche Business Overview
Table 84. Roche Cell therapy Processing Product
Table 85. Roche Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 86. Roche Recent Development
Table 87. FuGENE Company Details
Table 88. FuGENE Business Overview
Table 89. FuGENE Cell therapy Processing Product
Table 90. FuGENE Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 91. FuGENE Recent Development
Table 92. IBC Pharmaceuticals Inc. Company Details
Table 93. IBC Pharmaceuticals Inc. Business Overview
Table 94. IBC Pharmaceuticals Inc. Cell therapy Processing Product
Table 95. IBC Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 96. IBC Pharmaceuticals Inc. Recent Development
Table 97. Bluebird Bio Inc. Company Details
Table 98. Bluebird Bio Inc. Business Overview
Table 99. Bluebird Bio Inc. Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 100. Bluebird Bio Inc. Recent Development
Table 101. Immodulon-Therapeutics Company Details
Table 102. Immodulon-Therapeutics Business Overview
Table 103. Immodulon-Therapeutics Cell therapy Processing Product
Table 104. Immodulon-Therapeutics Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 105. Immodulon-Therapeutics Recent Development
Table 106. Immunomedics Inc. Company Details
Table 107. Immunomedics Inc. Business Overview
Table 108. Immunomedics Inc. Cell therapy Processing Product
Table 109. Immunomedics Inc. Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 110. Immunomedics Inc. Recent Development
Table 111. Juno Therapeutics Inc. Company Details
Table 112. Juno Therapeutics Inc. Business Overview
Table 113. Juno Therapeutics Inc. Cell therapy Processing Product
Table 114. Juno Therapeutics Inc. Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 115. Juno Therapeutics Inc. Recent Development
Table 116. Medlmmune Inc. Company Details
Table 117. Medlmmune Inc. Business Overview
Table 118. Medlmmune Inc. Cell therapy Processing Product
Table 119. Medlmmune Inc. Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 120. Medlmmune Inc. Recent Development
Table 121. NeoStem Oncology Company Details
Table 122. NeoStem Oncology Business Overview
Table 123. NeoStem Oncology Cell therapy Processing Product
Table 124. NeoStem Oncology Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 125. NeoStem Oncology Recent Development
Table 126. Neurotech USA Company Details
Table 127. Neurotech USA Business Overview
Table 128. Neurotech USA Cell therapy Processing Product
Table 129. Neurotech USA Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 130. Neurotech USA Recent Development
Table 131. Novartis Company Details
Table 132. Novartis Business Overview
Table 133. Novartis Cell therapy Processing Product
Table 134. Novartis Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 135. Novartis Recent Development
Table 136. Persimmune Inc. Company Details
Table 137. Persimmune Inc. Business Overview
Table 138. Persimmune Inc. Cell therapy Processing Product
Table 139. Persimmune Inc. Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 140. Persimmune Inc. Recent Development
Table 141. Pluristem Therapeutics Company Details
Table 142. Pluristem Therapeutics Business Overview
Table 143. Pluristem Therapeutics Cell therapy Processing Product
Table 144. Pluristem Therapeutics Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 145. Pluristem Therapeutics Recent Development
Table 146. BioMed Valley Discoveries Inc. Company Details
Table 147. BioMed Valley Discoveries Inc. Business Overview
Table 148. BioMed Valley Discoveries Inc. Cell therapy Processing Product
Table 149. BioMed Valley Discoveries Inc. Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 150. BioMed Valley Discoveries Inc. Recent Development
Table 151. Regeneron Pharmaceuticals Inc. Company Details
Table 152. Regeneron Pharmaceuticals Inc. Business Overview
Table 153. Regeneron Pharmaceuticals Inc. Cell therapy Processing Product
Table 154. Regeneron Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 155. Regeneron Pharmaceuticals Inc. Recent Development
Table 156. UCL Business PLC. Company Details
Table 157. UCL Business PLC. Business Overview
Table 158. UCL Business PLC. Cell therapy Processing Product
Table 159. UCL Business PLC. Revenue in Cell therapy Processing Business (2016-2021) & (US$ Million)
Table 160. UCL Business PLC. Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell therapy Processing Market Share by Type: 2020 VS 2027
Figure 2. Products Features
Figure 3. Services Features
Figure 4. Software Features
Figure 5. Global Cell therapy Processing Market Share by Application: 2020 VS 2027
Figure 6. Cardiovascular Disease Case Studies
Figure 7. Bone Repair Case Studies
Figure 8. Neurological Disorders Case Studies
Figure 9. Skeletal Muscle RepairImmune Diseases Case Studies
Figure 10. Cell therapy Processing Report Years Considered
Figure 11. Global Cell therapy Processing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cell therapy Processing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cell therapy Processing Market Share by Regions: 2020 VS 2027
Figure 14. Global Cell therapy Processing Market Share by Regions (2022-2027)
Figure 15. Global Cell therapy Processing Market Share by Players in 2020
Figure 16. Global Top Cell therapy Processing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell therapy Processing as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cell therapy Processing Revenue in 2020
Figure 18. Global Cell therapy Processing Revenue Market Share by Type (2016-2021)
Figure 19. Global Cell therapy Processing Revenue Market Share by Type (2022-2027)
Figure 20. North America Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cell therapy Processing Market Share by Type (2016-2027)
Figure 22. North America Cell therapy Processing Market Share by Application (2016-2027)
Figure 23. North America Cell therapy Processing Market Share by Country (2016-2027)
Figure 24. United States Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cell therapy Processing Market Share by Type (2016-2027)
Figure 28. Europe Cell therapy Processing Market Share by Application (2016-2027)
Figure 29. Europe Cell therapy Processing Market Share by Country (2016-2027)
Figure 30. Germany Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cell therapy Processing Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cell therapy Processing Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cell therapy Processing Market Share by Region (2016-2027)
Figure 40. China Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cell therapy Processing Market Share by Type (2016-2027)
Figure 48. Latin America Cell therapy Processing Market Share by Application (2016-2027)
Figure 49. Latin America Cell therapy Processing Market Share by Country (2016-2027)
Figure 50. Mexico Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cell therapy Processing Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cell therapy Processing Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cell therapy Processing Market Share by Country (2016-2027)
Figure 56. Turkey Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cell therapy Processing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Anthrogenesis Corp. Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 60. BioNTech Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 61. Cell Ideas Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 62. Epic Sciences Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 64. FuGENE Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 65. IBC Pharmaceuticals Inc. Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 66. Bluebird Bio Inc. Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 67. Immodulon-Therapeutics Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 68. Immunomedics Inc. Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 69. Juno Therapeutics Inc. Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 70. Medlmmune Inc. Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 71. NeoStem Oncology Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 72. Neurotech USA Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 73. Novartis Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 74. Persimmune Inc. Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 75. Pluristem Therapeutics Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 76. BioMed Valley Discoveries Inc. Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 77. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 78. UCL Business PLC. Revenue Growth Rate in Cell therapy Processing Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
世界の個別化細胞療法市場規模・現状・予測（2021年-2027年） The patient-tailored therapies for the treatment of variety of disease are known as personalized cell therapy. The personalized cell therapy is based on genomic profile, and disease prevalence/severity and the drug developed by this therapy target the patients who matches the specific disease physio…- 世界の胎盤幹細胞療法市場規模・現状・予測（2021年-2027年） Placental stem cells are cells derived from the placental blood and other body fluids of a new-born baby. Stem cells are human cells classified into a different variety of cell types, including brain and muscle cells. Stem cells are sometimes used in the development of regenerative therapies. Regene…
- 世界の自己細胞療法市場規模・現状・予測（2021年-2027年） Autologous cell therapy refers to the injection or delivery of human tissue or cells to the same person to treat pathological conditions. For the same purpose, the stem cells are taken out of the patient, harvested, cultured, and transplanted again to the same person. The purpose of this method is t…
- 世界の細胞治療バイオプロセス市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cell Therapy Bioprocessing Market The global Cell Therapy Bioprocessing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, …
- 世界の同種異系幹細胞治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Allogeneic Stem Cell Therapy Market The global Allogeneic Stem Cell Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…